ATE420101T1 - Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern - Google Patents
Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkernInfo
- Publication number
- ATE420101T1 ATE420101T1 AT02731460T AT02731460T ATE420101T1 AT E420101 T1 ATE420101 T1 AT E420101T1 AT 02731460 T AT02731460 T AT 02731460T AT 02731460 T AT02731460 T AT 02731460T AT E420101 T1 ATE420101 T1 AT E420101T1
- Authority
- AT
- Austria
- Prior art keywords
- molecules
- stem cells
- identified
- neural
- markers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28540701P | 2001-04-20 | 2001-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE420101T1 true ATE420101T1 (de) | 2009-01-15 |
Family
ID=23094102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02731460T ATE420101T1 (de) | 2001-04-20 | 2002-04-22 | Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern |
Country Status (7)
Country | Link |
---|---|
US (2) | US7419825B2 (de) |
EP (1) | EP1425297B1 (de) |
AT (1) | ATE420101T1 (de) |
AU (1) | AU2002303437A1 (de) |
CA (1) | CA2444706C (de) |
DE (1) | DE60230774D1 (de) |
WO (1) | WO2002086082A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040214766A1 (en) * | 2001-10-01 | 2004-10-28 | Kari Alitalo | VEGF-C or VEGF-D materials and methods for treatment of neuropathologies |
US20030186335A1 (en) * | 2002-03-28 | 2003-10-02 | National Institute Of Advanced Industrial Science And Technology | Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method |
JP2006511206A (ja) | 2002-08-27 | 2006-04-06 | ステムセルズ, インコーポレイテッド | 富化された中枢神経系幹細胞集団および前駆体細胞集団、ならびにこれらの集団を同定し、単離し、そして富化する方法 |
US8642332B2 (en) * | 2003-03-07 | 2014-02-04 | Cornell Research Foundation, Inc. | Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain |
US20040203142A1 (en) * | 2003-04-14 | 2004-10-14 | Reliance Life Sciences Pvt. Ltd. | Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation thereof for therapeutic purposes |
JP5099288B2 (ja) * | 2003-09-09 | 2012-12-19 | 学校法人慶應義塾 | 神経幹細胞の生存及び/又は増殖及び神経突起伸張を促進する方法並びに促進剤、神経幹細胞を含む医薬組成物、検定方法、スクリーニング方法 |
US7259011B2 (en) * | 2004-05-20 | 2007-08-21 | Paul Lucas | Pluripotent adult stem cells |
WO2008097828A2 (en) * | 2007-02-02 | 2008-08-14 | St. Jude Children's Research Hospital | Method for isolating mesenchymal stromal cells |
EP2022848A1 (de) | 2007-08-10 | 2009-02-11 | Hubrecht Institut | Verfahren zur Identifikation, Vermehrung und Entfernung erwachsener Stammzellen und Krebsstammzellen |
KR101972610B1 (ko) | 2011-05-18 | 2019-04-25 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 망막 질환을 치료하기 위한 조성물 및 방법 |
WO2013130603A1 (en) * | 2012-02-27 | 2013-09-06 | Board Of Regents, The University Of Texas System | Ganglioside gd2 as a marker and target on cancer stem cells |
WO2014113704A2 (en) * | 2013-01-18 | 2014-07-24 | Escape Therapeutics, Inc. | Enhanced differentiation of mesenchymal stem cells |
JP2016533770A (ja) * | 2014-09-05 | 2016-11-04 | コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジーKorea Research Institute Of Bioscience And Biotechnology | Gm1ガングリオシドーシスのヒト細胞モデルおよびその使用 |
JP2019508502A (ja) * | 2016-03-09 | 2019-03-28 | エーエーエル サイエンティフィックス,インコーポレイテッド | 神経幹細胞およびその使用 |
JP2018011527A (ja) * | 2016-07-19 | 2018-01-25 | 学校法人藤田学園 | 視床下部前駆細胞の精製方法及びその利用 |
US20190369093A1 (en) * | 2016-08-17 | 2019-12-05 | Xintela Ab | Marker for Neural Stem Cells |
GB201615714D0 (en) | 2016-09-15 | 2016-11-02 | Univ Of Sheffield The | Otic progenitor identification and isolation |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646001A (en) * | 1991-03-25 | 1997-07-08 | Immunivest Corporation | Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof |
EP0658194A1 (de) | 1992-07-27 | 1995-06-21 | California Institute Of Technology | Multipotenten neuronalen säugetierstammzellen |
US5693482A (en) | 1992-07-27 | 1997-12-02 | California Institute Of Technology | Neural chest stem cell assay |
US5466572A (en) * | 1992-09-03 | 1995-11-14 | Systemix, Inc. | High speed flow cytometric separation of viable cells |
DE69434974T2 (de) * | 1993-03-29 | 2008-02-07 | Kyowa Hakko Kogyo K.K. | alpha-2,8 SIALYLTRANSFERASE |
US5550019A (en) * | 1993-05-26 | 1996-08-27 | La Jolla Cancer Research Foundation | Methods of identifying compounds which alter apoptosis |
US5843633A (en) * | 1996-04-26 | 1998-12-01 | Amcell Corporation | Characterization of a human hematopoietic progenitor cell antigen |
US6235527B1 (en) * | 1997-11-29 | 2001-05-22 | University Of Utah Research Foundation | Lineage restricted glial precursors from the central nervous system |
CA2311729A1 (en) * | 1998-01-23 | 1999-07-29 | Imclone Systems Incorporated | Purified populations of stem cells |
US6468794B1 (en) * | 1999-02-12 | 2002-10-22 | Stemcells, Inc. | Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
JP2006511206A (ja) | 2002-08-27 | 2006-04-06 | ステムセルズ, インコーポレイテッド | 富化された中枢神経系幹細胞集団および前駆体細胞集団、ならびにこれらの集団を同定し、単離し、そして富化する方法 |
-
2002
- 2002-04-22 CA CA2444706A patent/CA2444706C/en not_active Expired - Lifetime
- 2002-04-22 AU AU2002303437A patent/AU2002303437A1/en not_active Abandoned
- 2002-04-22 DE DE60230774T patent/DE60230774D1/de not_active Expired - Lifetime
- 2002-04-22 US US10/128,009 patent/US7419825B2/en not_active Expired - Fee Related
- 2002-04-22 EP EP02731460A patent/EP1425297B1/de not_active Expired - Lifetime
- 2002-04-22 AT AT02731460T patent/ATE420101T1/de not_active IP Right Cessation
- 2002-04-22 WO PCT/US2002/012689 patent/WO2002086082A2/en not_active Application Discontinuation
-
2007
- 2007-11-02 US US11/934,597 patent/US8241897B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2444706C (en) | 2015-06-30 |
CA2444706A1 (en) | 2002-10-31 |
US7419825B2 (en) | 2008-09-02 |
EP1425297A2 (de) | 2004-06-09 |
US20080213893A1 (en) | 2008-09-04 |
US20030040023A1 (en) | 2003-02-27 |
DE60230774D1 (de) | 2009-02-26 |
AU2002303437A1 (en) | 2002-11-05 |
EP1425297B1 (de) | 2009-01-07 |
EP1425297A4 (de) | 2005-10-19 |
WO2002086082A3 (en) | 2004-04-08 |
US8241897B2 (en) | 2012-08-14 |
WO2002086082A2 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE420101T1 (de) | Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern | |
Haas et al. | Adult stem cell therapy in stroke | |
Bernal et al. | Neural stem cells as therapeutic agents for age‐related brain repair | |
NO20051030L (no) | Funksjonelle kardiomyocytter fra humane embryonale stamceller | |
CA2338541A1 (en) | Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy | |
WO2005046570A3 (en) | Human stem cell materials and methods | |
WO2007051038A3 (en) | Pdx1-expressing dorsal and ventral foregut endoderm | |
SG152273A1 (en) | Pdx1 expressing endoderm | |
WO2002092756A8 (en) | Insulin producing cells derived from human embryonic stem cells | |
MX2009006685A (es) | Antagonistas del dr6 y usos de los mismos en el tratamiento de trastornos neurologicos. | |
Kunkel et al. | Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs | |
DE69837491D1 (de) | Menschliche mesenchymale stammzellen aus peripherem blut | |
WO2003016507A3 (en) | Generation of multipotent central nervous system stem cells | |
WO2006060709A3 (en) | Biological pathways in progenitor cells | |
BRPI0412715A (pt) | células precursoras de oligodendrócitos e métodos de obter e cultivar as mesmas | |
WO2000066730A3 (en) | Laminin 2 and methods for its use | |
WO2006044842A3 (en) | Pancreatic islet beta-cell-like macrophages and methods to produce them | |
NO971341D0 (no) | Promoter for reseptor tyrosinkinase TIE | |
YU217890A (sh) | Postupak za dobijanje genetskih konstrukcija za ekspresiju nervnog faktora rasta u eukariotskim ćelijama | |
WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
DE60044655D1 (de) | Angereicherte Zellpopulationen des zentralen Nervensystems | |
WO2004043990A3 (en) | Human stem cell materials and methods | |
BR9906926A (pt) | Composições e métodos para tratamento de células tendo dna de minuto duplo | |
EP2377922A3 (de) | PDX1-exprimierendes Endoderm | |
WO2001042784A3 (en) | Methods for screening compounds active on neurons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |